Monopar Therapeutics
MNPR
$0.60
Share price
-9.38%
Change (1 day)
-30.45%
Change (1 year)
Categories
Earnings for Monopar Therapeutics (MNPR)
Earnings in 2023 (TTM): -$8.41 M
According to Monopar Therapeutics's latest financial reports the company's current earnings (TTM) are -$8.41 M. In 2022 the company made an earning of -$10.52 M a decrease over its 2021 earnings that were of -$9.11 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Monopar Therapeutics from 2017 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$8.41 M | -20.1% |
| 2022 | -$10.52 M | 15.52% |
| 2021 | -$9.11 M | 44.39% |
| 2020 | -$6.31 M | 49.23% |
| 2019 | -$4.23 M | 28.04% |
| 2018 | -$3.3 M | -80.07% |
| 2017 | -$16.56 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | 1,218.46% | 🇺🇸 USA |